Inquiry Basket
Loading ......
African swine fever (ASF) represents one of the most formidable threats to the global agricultural economy and animal welfare in modern history. Caused by the African swine fever virus (ASFV), this highly contagious hemorrhagic disease affects domestic pigs and wild boars, with mortality rates frequently approaching 100% in acute cases. Unlike many other severe viral diseases of livestock, the relentless expansion of ASF across multiple continents has severely disrupted international trade, decimated domestic pork production, and threatened global food security. The contemporary scientific discourse and popular search trends surrounding ASFV are heavily dominated by its unprecedented epidemiological spread and the intensive, high-stakes race to develop a safe, efficacious vaccine.
The structural biology and genomic complexity of ASFV make it a highly unique pathogen. It is a remarkably complex, large, double-stranded DNA virus and the sole member of the family Asfarviridae, genus Asfivirus. It is also uniquely categorized as the only known DNA arbovirus, heavily relying on soft ticks of the Ornithodoros genus for its natural transmission cycle in specific ecological niches. The virion exhibits an intricate multi-layered architecture consisting of an internal nucleoid containing the viral genome, a core shell, an inner lipid envelope, an icosahedral protein capsid, and, frequently, an outer lipid envelope acquired as the virus buds from the host cell membrane.
Figure 1. Schematic of African swine fever virus.
(Source: Gallagher JR, et al. 2020)
The ASFV genome is notably massive, ranging from 170 to 193 kilobase pairs depending on the specific isolate, and encodes over 150 structurally and functionally diverse viral proteins. This immense coding capacity equips the virus with an extensive arsenal of molecular tools designed to orchestrate cellular infection, replicate its genome, and subvert the host's immune defenses. Furthermore, the structural robustness of the ASFV virion contributes significantly to its epidemiological success. The virus exhibits extraordinary environmental resilience, remaining infectious for extended periods in harsh conditions. It can survive for months in contaminated environments, biological matrices, carcasses, and various pork products, including cured and frozen meats. This unprecedented durability poses a massive challenge for biosecurity and decontamination efforts on affected swine premises.
The pathogenesis of acute ASF is driven by the virus's ability to target and hijack the host's immune system. The primary cellular targets for ASFV infection are cells of the mononuclear phagocytic system, predominantly macrophages and monocytes. By infecting these critical sentinels, ASFV secures a highly permissive environment for massive viral replication while effectively disarming the frontline defenses. The resulting infection is characterized by severe lymphoid tissue destruction, extensive vascular damage, pulmonary edema, and widespread disseminated intravascular coagulation, culminating in a rapid and fatal hemorrhagic syndrome.
A major focus of current molecular virology research is deciphering the intricate mechanisms by which ASFV evades host immunity. The virus expresses numerous immunomodulatory proteins that systematically block the production and signaling pathways of type I interferons, which are essential for establishing an antiviral state in neighboring tissues. Additionally, ASFV encodes viral homologs of cellular proteins designed to inhibit apoptosis in the early stages of infection, preventing premature host cell death and ensuring maximal viral progeny production. Conversely, in the later stages, the virus induces massive apoptosis in uninfected lymphocytes through indirect mechanisms, leading to severe lymphopenia and profound immunosuppression.
Historically, ASFV was confined predominantly to the African continent within a sylvatic cycle involving asymptomatic wild suids, such as warthogs, and soft ticks. However, the global epidemiological landscape has undergone a dramatic and catastrophic shift. The introduction of the highly virulent genotype II ASFV into the Caucasus region in 2007 marked the beginning of a relentless transcontinental panzootic. The virus subsequently swept through Eastern Europe, the Russian Federation, and into Asia, fundamentally altering the global swine industry. More recently, the reappearance of ASFV in the Western Hemisphere has triggered profound international alarm.
Figure 2. Global distribution of ASF, 2005–2020.
(Source: Shi J, et al. 2021)
The transmission dynamics in these newly invaded territories are incredibly complex, driven largely by human-mediated activities. While direct contact between infected and susceptible animals is highly efficient, the primary drivers of long-distance geographic spread are anthropogenic. The movement of contaminated pork products, contaminated fomites—such as transport vehicles, clothing, and farming equipment—and the feeding of virus-contaminated swill to domestic pigs represent the most critical risk factors. Additionally, in regions such as Europe, the establishment of an independent infection cycle within wild boar populations has created an intractable wildlife reservoir, making disease eradication efforts exceptionally difficult and necessitating sustained, intensive wildlife management strategies.
The development of a safe and effective vaccine against ASFV remains the ultimate goal of veterinary virology and a continuous focus of agricultural research. Traditional vaccine approaches, such as inactivated or killed vaccines, have repeatedly failed to confer protective immunity, largely due to the virus's complex immune evasion strategies and the absolute necessity for a robust cellular immune response. Consequently, the scientific consensus has strongly pivoted toward live-attenuated vaccines. Utilizing advanced reverse genetics, researchers have successfully engineered vaccine candidates by systematically deleting specific virulence-associated genes from the viral genome. These gene-deleted strains have demonstrated significant promise in providing homologous protection against currently circulating field strains.
Despite these scientific breakthroughs, the path to widespread global application is fraught with stringent regulatory and safety hurdles. A primary biological concern is the potential for live vaccine strains to revert to virulence or cause chronic disease, particularly in immunocompromised herds. Furthermore, modern ASFV vaccine strategies must strictly adhere to the DIVA (Differentiating Infected from Vaccinated Animals) principle. The incorporation of negative genetic markers ensures that surveillance authorities can clearly distinguish vaccine-induced antibodies from those resulting from natural field infection. This capability is absolutely non-negotiable for the safe resumption and regulation of international pork trade. As genomic research accelerates, the global veterinary community remains focused on refining these molecular innovations to yield a highly regulated, safe, and universally deployable prophylactic tool.
References
| Target | Cat. No. | Product Name | Size | Species | Application | |
| ASFV | DEIA-NS2309-3 | African Swine fever Antibodies ELISA Kit | 192T | Porcine | Qualitative | Inquiry |
| DEIA-NS2309-2 | ASFV Antibody (P72) Blocking ELISA kit | 192T | Porcine | Qualitative | Inquiry | |
| DEIA-NS2309-4 | African Swine fever Virus ELISA Antibody (P54) Test Kit | 96T | Porcine | Qualitative | Inquiry | |
| DEIA-NS2309-5 | African Swine fever Virus ELISA Antibody (P30) Test Kit | 96T | Porcine | Qualitative | Inquiry |
Loading ......
